These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17766765)
1. Evaluating the cost-effectiveness of reduced tardive dyskinesia with second-generation antipsychotics. Rosenheck RA Br J Psychiatry; 2007 Sep; 191():238-45. PubMed ID: 17766765 [TBL] [Abstract][Full Text] [Related]
2. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Dolder CR; Jeste DV Biol Psychiatry; 2003 Jun; 53(12):1142-5. PubMed ID: 12814866 [TBL] [Abstract][Full Text] [Related]
3. Tardive dyskinesia and new antipsychotics. Correll CU; Schenk EM Curr Opin Psychiatry; 2008 Mar; 21(2):151-6. PubMed ID: 18332662 [TBL] [Abstract][Full Text] [Related]
4. [Dose reduction of conventional antipsychotics: does it reduce tardive dyskinesia?]. van Berkel M; Bogers JP; Bouvy PF Tijdschr Psychiatr; 2007; 49(1):37-41. PubMed ID: 17225204 [TBL] [Abstract][Full Text] [Related]
5. Tardive dyskinesia rates with atypical antipsychotics in older adults. Jeste DV J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. Rosenheck RA; Leslie DL; Sindelar J; Miller EA; Lin H; Stroup TS; McEvoy J; Davis SM; Keefe RS; Swartz M; Perkins DO; Hsiao JK; Lieberman J; Am J Psychiatry; 2006 Dec; 163(12):2080-9. PubMed ID: 17151158 [TBL] [Abstract][Full Text] [Related]
7. Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study. Tenback DE; van Harten PN; Slooff CJ; Belger MA; van Os J; J Clin Psychiatry; 2005 Sep; 66(9):1130-3. PubMed ID: 16187770 [TBL] [Abstract][Full Text] [Related]
8. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs]. Seigneurie AS; Sauvanaud F; Limosin F Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134 [TBL] [Abstract][Full Text] [Related]
9. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Woerner MG; Alvir JM; Saltz BL; Lieberman JA; Kane JM Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112 [TBL] [Abstract][Full Text] [Related]
10. Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Nasrallah HA Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454 [TBL] [Abstract][Full Text] [Related]
17. [Tardive dyskinesia and second generation antipsychotics: a review of four cases]. Van Wijnendaele R; Dagrada H; Leblanc P Rev Med Brux; 2015; 36(5):405-9. PubMed ID: 26749629 [TBL] [Abstract][Full Text] [Related]
18. [Utility of quetiapine in tardive dyskinesia]. Navarro Pacheco BV; Montejo González AL; Martín Carrasco M Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511 [TBL] [Abstract][Full Text] [Related]
19. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study. Ryu S; Yoo JH; Kim JH; Choi JS; Baek JH; Ha K; Kwon JS; Hong KS J Clin Psychopharmacol; 2015 Feb; 35(1):13-21. PubMed ID: 25485636 [TBL] [Abstract][Full Text] [Related]
20. The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population. Brar JS; Parepally H; Chalasani L; Gopalani A; Appel N; Chengappa KN Ann Clin Psychiatry; 2008; 20(3):139-44. PubMed ID: 18633740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]